Richards Guy A, Perovic Olga, Brink Adrian J
Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
AMR Division at WITS Health Consortium, Pathologist Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses (CHARM), at the National Institute for Communicable Diseases, a division of NHLS and the University of the Witwatersrand, Johannesburg, South Africa.
Clin Microbiol Rev. 2024 Dec 10;37(4):e0009324. doi: 10.1128/cmr.00093-24. Epub 2024 Nov 18.
SUMMARYInfections due to spp. are among the most difficult to treat. Most are resistant to standard antibiotics, and there is difficulty in distinguishing colonizers from pathogens. This mini-review examines the available antibiotics that exhibit activity against these organisms and provides guidance as to which cultures are relevant and how to treat active infections. Antibiograms describing resistance mechanisms and the minimum inhibitory concentration (MIC) are essential to determine which agent or combination of agents should be used after confirmation of infection, utilizing clinical parameters and biomarkers such as procalcitonin. Directed therapy should be prompt as despite its reputation as a colonizer, the attributable mortality is high. However, although combination therapy is advised, no specific combination has definite evidence of superiority.
由[具体菌种]引起的感染是最难治疗的感染之一。大多数此类感染对标准抗生素耐药,且难以区分定植菌和病原菌。本综述探讨了对这些微生物有活性的现有抗生素,并就哪些培养结果具有相关性以及如何治疗活动性感染提供指导。描述耐药机制和最低抑菌浓度(MIC)的抗菌谱对于在确认感染后利用临床参数和生物标志物(如降钙素原)来确定应使用哪种药物或药物组合至关重要。尽管[具体菌种]素有定植菌之名,但因其所致的死亡率较高,所以应迅速进行针对性治疗。然而,尽管建议联合治疗,但尚无明确证据表明哪种特定组合具有优越性。